Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7870784 | 0.86 | MAPK1 (0.38) | GAAUSP2SMN1; SMN2MAPK1RECQL | |
| SCHEMBL7870788 | 0.86 | MAPK1 (0.38) | GAAUSP2SMN1; SMN2MAPK1RECQL | |
| SCHEMBL29988783 | 0.83 | USP2 (0.41) | GAAUSP2SMN1; SMN2MAPK1RECQL | |
| Hydrochloric Acid SCHEMBL29356070 | 0.81 | USP2 (0.40) | GAAUSP2SMN1; SMN2MAPK1RECQL | |
| SCHEMBL28273690 | 0.81 | USP2 (0.36) | GAAUSP2SMN1; SMN2MAPK1RECQL | |
| SCHEMBL18175961 | 0.81 | ELANE (0.33) | — | |
| SCHEMBL29238084 | 0.81 | — | — | |
| SCHEMBL29238085 | 0.79 | — | — | |
| SCHEMBL1863442 | 0.78 | — | — | |
| SCHEMBL6510742 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20190198928-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| US-10263285-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-04-16 | — | — | US | disclosed |
| US-20180166746-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| US-20180166746-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| EP-3086396-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE Industries, Ltd. (JP) | 2016-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180166746-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | GAA 4518/4885USP2 3807/4885SMN1; SMN2 3968/4885 |
| US-20190198928-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | GAA 4518/4885USP2 3807/4885SMN1; SMN2 3968/4885 |
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | GAA 4518/4885USP2 3807/4885SMN1; SMN2 3968/4885 |
| US-10263285-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | GAA 4518/4885USP2 3807/4885SMN1; SMN2 3968/4885 |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | GAA 4518/4885USP2 3807/4885SMN1; SMN2 3968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.